Level up your trading with our powerful tools and real-time insights all in one place.
The current KRBP market cap is 1.67M. The company's latest EPS is USD -17.5429 and P/E is -0.03.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.2M | -25.31M | -31.11M | -19.94M | -23.77M |
| Net Income | -19.2M | -25.59M | -34.73M | -20.95M | -26.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.83M | 30.73M | 11.97M | 12.17M | 8.55M |
| Total Liabilities | 1.47M | 3.41M | 17.74M | 21.29M | 21.13M |
| Total Equity | 11.36M | 27.32M | -5.78M | -9.12M | -12.59M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.13M | -20.32M | -23.75M | -21.23M | -19.46M |
| Investing | -1.46M | -1.81M | -4.87M | -207k | -366k |
| Financing | 15.81M | 37.34M | 3.9M | 23.99M | 18.42M |
| Market Cap | 1.67M |
| Price to Earnings Ratio | -0.03 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.81 |
| Price to Book Ratio | -0.07 |
| Dividend Yield | - |
| Shares Outstanding | 1.53M |
| Average Volume (1 week) | 296 |
| Average Volume (1 Month) | 762 |
| 52 Week Change | -53.81% |
| 52 Week High | 3.65 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 0.33 (20.62%) |
| Company Name | Kiromic BioPharma Inc (QB) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://kiromic.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
